Medline UNITE has received 510(k) clearance from the FDA for its latest implant family, the REFLEX HYBRID Nitinol Implant System.
While nitinol staples have steadily risen in popularity, static plates and screws are widely used in conjunction with staples to provide added fixation and stability. A key disadvantage of such hybrid constructs is the inherent neutralization of compression caused by the addition of static devices such as locking plates and cannulated screws. REFLEX HYBRID combines the compression of a nitinol staple with the stability of a locking plate, offering indication-specific implants designed for MTP fusions and Lapidus procedures. When paired with a cannulated screw with a Dynamic Disc, or a REFLEX nitinol staple, the construct provides dynamic biplanar compression and fixation for a fully dynamic construct.
The system includes an innovative inserter that allows the surgeon to expand the implant’s legs for a streamlined technique. Because both of the implant’s legs are on the same side of the joint, the surgeon has the flexibility to adjust the placement of the implant, which is not possible with other nitinol solutions on the market.
Jonathon Backus, MD of the Steadman Clinic in Vail, CO conducted extensive testing comparing a REFLEX HYBRID and cannulated screw construct to traditional titanium plate and screw, and nitinol staple and screw constructs.
“Biomechanical testing results showed using a HYBRID implant with a screw provides a statistically significant better load to failure and gapping at failure result than a traditional titanium plate and screw construct. Historically, nitinol constructs have not performed better than traditional plate and screw constructs with such testing,” he said.
